Hummingbird Bioscience

View the org chart displaying its 19 main executives

Most searched biographies at Hummingbird Bioscience

• Piers Ingram, Chief Executive Officer and Executive Director
• Victor Tong, Director
• Dan Estes, Director

Popular executive movements at Hummingbird Bioscience

• Angèle Maki has joined the company as Chief Business Officer  (posted on December 11 2023).

Create your alert
to follow the executive moves at Hummingbird Bioscience.

Hummingbird Bioscience has 2,290 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Aardvark Therapeutics has just announced a $85 Million fundraising (posted on May 12 2024).
• Bluejay Therapeutics has just announced a $182 Million fundraising (posted on May 12 2024).
• Delphia Therapeutics has just announced a $67 Million fundraising (posted on May 7 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Carl Gordon - Director at Adicet Bio
• Vik Bajaj - Director at Interline Therapeutics

Learn more about the Biotechnology industry >

Press releases by Hummingbird Bioscience

• News – 2024 | Hummingbird Bioscience
• Journal for ImmunoTherapy of Cancer: P477 HMBD-002-V4: A novel anti-VISTA antibody that uniquely binds murine and human VISTA and potently inhibits tumor growth by remodeling the immunosuppressive tumor microenvironment | Hummingbird Bioscience
• Hummingbird Bioscience Publishes Preclinical Data Demonstrating Therapeutic Potential of HMBD-002 in VISTA-expressing Cancers | Hummingbird Bioscience
• Journal for ImmunoTherapy of Cancer: Rationally targeted anti-VISTA antibody that blockades the C-C’ loop region can reverse VISTA immune suppression and remodel the immune microenvironment to potently inhibit tumor growth in an Fc independent manner. | H
• New biotech facility Hummingbird Bioscience opens | Video
• Hummingbird Bioscience Announces First Patient Dosed in Phase 1 Clinical Trial of HMBD-001 in Advanced HER3-Expressing Solid Malignancies - Hummingbird Bioscience
• Hummingbird Bioscience Publishes Preclinical Data Demonstrating Therapeutic Potential of HMBD-002 in VISTA-expressing Cancers - Hummingbird Bioscience
• News – Hummingbird
• View more press releases Close

Social media about Hummingbird Bioscience

• Hummingbird Bioscience on Wikipedia, Google News & Yahoo Finance
• Hummingbird Bioscience on LinkedIn, Twitter & YouTube

Contact by email its executives including Piers Ingram

Call Hummingbird Bioscience at +65 ...

View the org chart

Register to receive your alert

Report an error